Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers (Q99551841)
Jump to navigation
Jump to search
scientific article published on 01 September 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers |
scientific article published on 01 September 2020 |
Statements
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers (English)
Rod Balhorn
Monique Cosman Balhorn
1 September 2020